Enovis Corp Financing Receivable, Allowance for Credit Loss, Writeoff
Enovis Corp (ENOV) reported Financing Receivable, Allowance for Credit Loss, Writeoff of $2.63 million for the 6-month period ending 2026-07-03, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:FinancingReceivableAllowanceForCreditLossesWriteOffs · last filed 2026-08-06
- Enovis Corp financing receivable, allowance for credit loss, writeoff for the quarter ending 2026-07-03 was $2.28M, a 792.55% increase year-over-year.
- Enovis Corp financing receivable, allowance for credit loss, writeoff for the quarter ending 2026-04-03 was $357.00K, a 43.87% decline year-over-year.
- Enovis Corp financing receivable, allowance for credit loss, writeoff for the quarter ending 2025-12-31 was $2.21M, a 2.65% increase year-over-year.
- Enovis Corp financing receivable, allowance for credit loss, writeoff for the quarter ending 2025-10-03 was $78.00K, a 85.17% decline year-over-year.
- Enovis Corp financing receivable, allowance for credit loss, writeoff for fiscal 2025 was $3.17M, a 23.43% decline from fiscal 2024.
- Enovis Corp financing receivable, allowance for credit loss, writeoff for fiscal 2024 was $4.14M, a 28.69% increase from fiscal 2023.
- Enovis Corp financing receivable, allowance for credit loss, writeoff for fiscal 2023 was $3.22M, a 234.48% increase from fiscal 2022.
- Enovis Corp financing receivable, allowance for credit loss, writeoff for fiscal 2022 was $963.00K, a 85.58% decline from fiscal 2021.
| Period end | Financing Receivable, Allowance for Credit Loss, Writeoff 3 month | Financing Receivable, Allowance for Credit Loss, Writeoff 6 month | Financing Receivable, Allowance for Credit Loss, Writeoff 9 month | Financing Receivable, Allowance for Credit Loss, Writeoff 12 month |
|---|---|---|---|---|
| 2026-07-03 | $2.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.63M 10-Q · filed 2026-08-06 | $4.84M derived: sum of 3 quarters · filed 2026-08-06 | $4.92M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-04-03 | $357.00K 10-Q · filed 2026-05-07 | $2.56M derived: sum of 2 quarters · filed 2026-05-07 | $2.64M derived: sum of 3 quarters · filed 2026-05-07 | $2.90M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | $2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.28M derived: sum of 2 quarters · filed 2026-02-26 | $2.54M derived: sum of 3 quarters · filed 2026-02-26 | $3.17M 10-K · filed 2026-02-26 |
| 2025-10-03 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $333.00K derived: sum of 2 quarters · filed 2025-11-06 | $969.00K 10-Q · filed 2025-11-06 | $3.12M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-07-04 | $255.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $891.00K 10-Q · filed 2025-08-07 | $3.04M derived: sum of 3 quarters · filed 2025-08-07 | $3.56M derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-04-04 | $636.00K 10-Q · filed 2025-05-08 | $2.78M derived: sum of 2 quarters · filed 2025-05-08 | $3.31M derived: sum of 3 quarters · filed 2025-05-08 | $3.84M derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $2.67M derived: sum of 2 quarters · filed 2025-02-26 | $3.21M derived: sum of 3 quarters · filed 2025-02-26 | $4.14M 10-K · filed 2025-02-26 |
| 2024-09-27 | $526.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $1.06M derived: sum of 2 quarters · filed 2024-11-06 | $2.00M 10-Q · filed 2024-11-06 | $2.72M derived: sum of 4 quarters · filed 2024-11-06 |
| 2024-06-28 | $531.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $1.47M 10-Q · filed 2024-08-07 | $2.19M derived: sum of 3 quarters · filed 2024-08-07 | $2.98M derived: sum of 4 quarters · filed 2024-08-07 |
| 2024-03-29 | $940.00K 10-Q · filed 2024-05-02 | $1.66M derived: sum of 2 quarters · filed 2024-05-02 | $2.45M derived: sum of 3 quarters · filed 2024-05-02 | $3.70M derived: sum of 4 quarters · filed 2024-05-02 |
| 2023-12-31 | $722.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $1.51M derived: sum of 2 quarters · filed 2024-02-22 | $2.76M derived: sum of 3 quarters · filed 2024-02-22 | $3.22M 10-K · filed 2024-02-22 |
| 2023-09-29 | $790.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $2.04M derived: sum of 2 quarters · filed 2023-11-07 | $2.50M 10-Q · filed 2023-11-07 | $1.44M derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $1.71M 10-Q · filed 2023-08-03 | $645.00K derived: sum of 3 quarters · filed 2023-08-03 | $1.28M derived: sum of 4 quarters · filed 2023-08-03 |
| 2023-03-31 | $463.00K 10-Q · filed 2023-05-04 | -$601.00K derived: sum of 2 quarters · filed 2023-05-04 | $35.00K derived: sum of 3 quarters · filed 2023-05-04 | $1.28M derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-12-31 | -$1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$428.00K derived: sum of 2 quarters · filed 2023-03-01 | $822.00K derived: sum of 3 quarters · filed 2023-03-01 | $963.00K 10-K · filed 2023-03-01 |
| 2022-09-30 | $636.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $1.89M derived: sum of 2 quarters · filed 2022-11-02 | $2.03M 10-Q · filed 2022-11-02 | $6.51M derived: sum of 4 quarters · filed 2022-11-02 |
| 2022-07-01 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.39M 10-Q · filed 2022-08-04 | $5.88M derived: sum of 3 quarters · filed 2022-08-04 | $4.63M derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-04-01 | $141.00K 10-Q · filed 2022-05-10 | $4.63M derived: sum of 2 quarters · filed 2022-05-10 | $3.38M derived: sum of 3 quarters · filed 2022-05-10 | $5.76M derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | $4.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $3.24M derived: sum of 2 quarters · filed 2022-02-22 | $5.62M derived: sum of 3 quarters · filed 2022-02-22 | $6.68M 10-K · filed 2022-02-22 |
| 2021-10-01 | -$1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.13M derived: sum of 2 quarters · filed 2021-11-04 | $2.19M 10-Q · filed 2021-11-04 | $3.11M derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-07-02 | $2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $3.44M 10-Q · filed 2021-07-28 | $4.35M derived: sum of 3 quarters · filed 2021-07-28 | $7.25M derived: sum of 4 quarters · filed 2021-07-28 |
| 2021-04-02 | $1.06M 10-Q · filed 2021-04-29 | $1.98M derived: sum of 2 quarters · filed 2021-04-29 | $4.87M derived: sum of 3 quarters · filed 2021-04-29 | $4.37M derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-12-31 | $914.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | $3.81M derived: sum of 2 quarters · filed 2021-02-18 | $3.30M derived: sum of 3 quarters · filed 2021-02-18 | $5.17M 10-K · filed 2021-02-18 |
| 2020-10-02 | $2.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $2.39M derived: sum of 2 quarters · filed 2020-10-29 | $4.25M 10-Q · filed 2020-10-29 | |
| 2020-07-03 | -$502.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.36M 10-Q · filed 2020-08-06 | ||
| 2020-04-03 | $1.86M 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |